Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Titles
NEW
 Top 50 Non-Healthcare Titles
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Cardiac Marker Global Market Report 2025
Request Sample Buy Now
Global Cardiac Marker Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Cardiac Marker Global Market Report 2025

By Biomarker (Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers), By Product (Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA), By Indication (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications), By End User (Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cardiac Marker Market Overview

• Cardiac Marker market size has reached to $11.26 billion in 2024

• Expected to grow to $20.05 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%

• Growth Driver: Cardiac Marker Market Surge Is Addressing The Growing Prevalence Of Cardiovascular Diseases

• Market Trend: Mirxes' Microrna-Based Diagnostic Test Revolutionizes Early Detection In The Cardiac Marker Market

• North America was the largest region in 2024.

What Is Covered Under Cardiac Marker Market?

Cardiac markers are biomolecules that are released into the bloodstream when there is damage or stress to the heart muscle. It is used to diagnose and monitor a variety of cardiac diseases, including heart attacks, angina, and heart failure.

The main types of cardiac markers are troponin, creatine kinase-MB (CK-MB), B-type natriuretic peptide (BNP), myoglobin, and other biomarkers. Troponin refers to a protein that is released into the bloodstream when there is damage to the heart muscle and is commonly used to diagnose and monitor heart-related conditions. The different products of cardiac markers are reagents, Instruments, Chemiluminescence, immunofluorescence, immunochromatography, and ELISA. It is applied for various indications, including myocardial infarction, congestive heart failure, acute coronary syndrome, and other indications, by end users such as laboratory testing facilities, hospital labs, reference labs, contract testing labs, point-of-care testing facilities, and academic institutions.

Cardiac Marker Market Size and growth rate 2025 to 2029: Graph

What Is The Cardiac Marker Market Size 2025 And Growth Rate?

The cardiac marker market size has grown rapidly in recent years. It will grow from$11.26 billion in 2024 to $12.38 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increased incidence of cardiovascular diseases, aging population and cardiovascular risk, awareness programs and health screenings, integration of biomarkers in clinical practice, stringent regulatory standards and guidelines

What Is The Cardiac Marker Market Growth Forecast?

The cardiac marker market size is expected to see rapid growth in the next few years. It will grow to $20.05 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to rising burden of lifestyle-related diseases, remote monitoring and telemedicine, personalized medicine and precision diagnostics, point-of-care testing (poct) adoption, collaborations and partnerships in healthcare. Major trends in the forecast period include biomarker discovery and validation, personalized medicine approaches, technological advancements in assay platforms, integration of high-sensitivity troponin tests, rise in cardiovascular disease prevalence.

The forecast of 12.8% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for creatine kinase (CK)-MB isoenzyme standards and B-type natriuretic peptide (BNP) calibration materials, sourced from key regions such as Belgium and Sweden, which could lead to compromised test accuracy and increased cardiac diagnostic costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How Is The Cardiac Marker Market Segmented?

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

What Is Driving The Cardiac Marker Market? Cardiac Marker Market Surge Is Addressing The Growing Prevalence Of Cardiovascular Diseases

The rising prevalence of cardiac diseases is expected to propel the growth of the cardiac marker market going forward. Cardiac diseases are a group of conditions that affect the structure or operation of the heart and cause a range of medical problems. Cardiac markers are used to diagnose and monitor various cardiac conditions, including heart attacks, angina, heart failure, and other cardiovascular diseases. Thus, the demand for diagnostic tests or cardiac markers has increased. For instance, according to the British Heart Foundation, a cardiovascular research charity in the UK, in England, there were 30,000 more deaths from coronary heart disease from the start of the pandemic to August 2022. A record 346,000 persons were on a cardiac waiting list by the end of August 2022. Therefore, the rising prevalence of cardiac diseases will fuel the cardiac marker industry's growth.

What Is Driving The Cardiac Marker Market? Diagnostic Center Surge Is A Catalyst For Accelerated Growth In The Cardiac Marker Market

The increasing demand in diagnostic centers is expected to propel the growth of the cardiac marker market going forward. Diagnostic centers are healthcare facilities that specialize in performing various medical tests and diagnostic procedures to identify, detect, and monitor health conditions. The use of cardiac markers in diagnostic centers provides valuable information for timely and accurate diagnosis, risk assessment, and the development of tailored treatment plans, ultimately contributing to improved patient outcomes in cardiovascular health. For instance, in April 2022, according to GOV.UK, a UK-based government digital service provider, 73 diagnostic centers operated and performed 30,000 more tests per week in 2022, and by 2025, there could be 160 community diagnostic centers. Therefore, the increasing demand in diagnostic centers is driving the growth of the cardiac marker industry.

Who Are The Major Players In The Global Cardiac Marker Market?

Major companies operating in the cardiac marker market include Abbott Laboratories Inc., Siemens AG, Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Guangzhou Wondifo Biotech Co. Ltd., Creative Diagnostics, PerkinElmer Inc., Tosoh Corporation, Quidel Corporation, Randox Laboratories Ltd., Getinge Group, LSI Medience Corporation, Ortho Clinical Diagnostics, DiaSorin, 3M Company, Atom Medical Corporation, Bionet America Inc., Bistos Inc., CareFusion Corporation, Clinical Innovations LLC, Abcam plc, General Electric Company

What Are The Key Trends Of The Global Cardiac Marker Market? Mirxes' Microrna-Based Diagnostic Test Revolutionizes Early Detection In The Cardiac Marker Market

Product innovation is a key trend gaining popularity in the cardiac marker market. Major market players are focusing on innovative solutions to strengthen their position in the market. For instance, in September 2022, MiRxes, a Singapore-based biotechnology company, validated a microRNA-based diagnostic test for the early detection and diagnosis of the illness. When commercialized, the test will enhance MiRxes' portfolio of blood tests for cancer, offering a full range of early detection options to lessen the increasing clinical and socioeconomic burden of life-threatening illnesses, including cancer and cardio-pulmonary disorders.

What Are The Key Trends Of The Global Cardiac Marker Market? Specialized Biomarker To Provide Reliable Services To Their Customers

Major companies operating in the cardiac marker market are focusing on innovative products such as high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers to drive revenues in their market. High-sensitivity troponin I (hs-cTnI) and NT-proBNP, two important cardiac biomarkers which are used to diagnose, classify, and treat. For instance, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. a China-based company that specializes in the development, manufacture, and distribution of medical equipment and solutions launched troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay has surpassed the minimal requirements for hs-cTn in terms of sensitivity, accuracy, and reliability in identifying myocardial damage. These new products are intended to support improved treatment for cardiovascular illnesses by giving dependable solutions that improve patient outcomes both within and beyond the context of cardiovascular illnesses.

Need data on a specific region in this market?
Request Customisation

Cardiac Marker Market Merger And Acquisition: Abbott Laboratories Expands Cardiovascular Portfolio With Strategic Acquisition Of Cardiovascular Systems Inc.

In April 2023, Abbott Laboratories, a US-based healthcare company acquired Cardiovascular Systems Inc. for an undisclosed amount. With this acquisition, Abbott will be able to better serve patients with peripheral and coronary artery disease by offering novel and cutting-edge therapy for those with complicated cardiovascular disease. Through this acquisition, Abbott is able to expand the range of cutting-edge vascular devices it offers doctors, giving them more resources to assist patients. Cardiovascular Systems Inc. is a US-based medical technology company.

Regional Analysis For The Global Cardiac Marker Market

North America was the largest region in the cardiac marker market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Cardiac Marker Market?

The cardiac marker market consists of sales of C-reactive protein (CRP) and Ischemia-modified albumin (IMA). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cardiac Marker Industry?

The cardiac marker market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac marker industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Cardiac Marker Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $12.38 billion
Revenue Forecast In 2034 $20.05 billion
Growth Rate CAGR of 12.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers
2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA
3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications
4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions Subsegments: 1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits
2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels
3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels
4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels
5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Abbott Laboratories Inc., Siemens AG, Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Guangzhou Wondifo Biotech Co. Ltd., Creative Diagnostics, PerkinElmer Inc., Tosoh Corporation, Quidel Corporation, Randox Laboratories Ltd., Getinge Group, LSI Medience Corporation, Ortho Clinical Diagnostics, DiaSorin, 3M Company, Atom Medical Corporation, Bionet America Inc., Bistos Inc., CareFusion Corporation, Clinical Innovations LLC, Abcam plc, General Electric Company
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Cardiac Marker Market Characteristics

3. Cardiac Marker Market Trends And Strategies

4. Cardiac Marker Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cardiac Marker Growth Analysis And Strategic Analysis Framework

5.1. Global Cardiac Marker PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cardiac Marker Market Growth Rate Analysis

5.4. Global Cardiac Marker Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cardiac Marker Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cardiac Marker Total Addressable Market (TAM)

6. Cardiac Marker Market Segmentation

6.1. Global Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Troponin

Creatine Kinase-MB (CK-MB)

B-type Natriuretic Peptide (BNP)

Myoglobin

Other Biomarkers

6.2. Global Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Reagent

Instrument

Chemiluminescence

Immunofluorescence

Immunochromatography

ELISA

6.3. Global Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Myocardial Infarction

Congestive Heart Failure

Acute Coronary Syndrome

Other Indications

6.4. Global Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Laboratory Testing Facilities

Hospital Labs

Reference Labs

Contract Testing Labs

Point-Of-Care Testing Facilities

Academic Institutions

6.5. Global Cardiac Marker Market, Sub-Segmentation Of Troponin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Troponin I

Troponin T

Troponin Diagnostic Kits

6.6. Global Cardiac Marker Market, Sub-Segmentation Of Creatine Kinase-MB (CK-MB), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

CK-MB Test Kits

CK-MB Diagnostic Panels

6.7. Global Cardiac Marker Market, Sub-Segmentation Of B-Type Natriuretic Peptide (BNP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

BNP Test Kits

NT-ProBNP Test Kits

BNP Diagnostic Panels

6.8. Global Cardiac Marker Market, Sub-Segmentation Of Myoglobin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Myoglobin Test Kits

Myoglobin Diagnostic Panels

6.9. Global Cardiac Marker Market, Sub-Segmentation Of Other Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ischemia Modified Albumin (IMA)

Heart Fatty Acid Binding Protein (HFABP)

C-Reactive Protein (CRP)

7. Cardiac Marker Market Regional And Country Analysis

7.1. Global Cardiac Marker Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cardiac Marker Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiac Marker Market

8.1. Asia-Pacific Cardiac Marker Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiac Marker Market

9.1. China Cardiac Marker Market Overview

9.2. China Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiac Marker Market

10.1. India Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiac Marker Market

11.1. Japan Cardiac Marker Market Overview

11.2. Japan Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiac Marker Market

12.1. Australia Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiac Marker Market

13.1. Indonesia Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiac Marker Market

14.1. South Korea Cardiac Marker Market Overview

14.2. South Korea Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiac Marker Market

15.1. Western Europe Cardiac Marker Market Overview

15.2. Western Europe Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiac Marker Market

16.1. UK Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiac Marker Market

17.1. Germany Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiac Marker Market

18.1. France Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiac Marker Market

19.1. Italy Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiac Marker Market

20.1. Spain Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiac Marker Market

21.1. Eastern Europe Cardiac Marker Market Overview

21.2. Eastern Europe Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiac Marker Market

22.1. Russia Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiac Marker Market

23.1. North America Cardiac Marker Market Overview

23.2. North America Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiac Marker Market

24.1. USA Cardiac Marker Market Overview

24.2. USA Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiac Marker Market

25.1. Canada Cardiac Marker Market Overview

25.2. Canada Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiac Marker Market

26.1. South America Cardiac Marker Market Overview

26.2. South America Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiac Marker Market

27.1. Brazil Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiac Marker Market

28.1. Middle East Cardiac Marker Market Overview

28.2. Middle East Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiac Marker Market

29.1. Africa Cardiac Marker Market Overview

29.2. Africa Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiac Marker Market Competitive Landscape And Company Profiles

30.1. Cardiac Marker Market Competitive Landscape

30.2. Cardiac Marker Market Company Profiles

30.2.1. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Siemens AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.4. BioMérieux SA Overview, Products and Services, Strategy and Financial Analysis

30.2.5. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

31. Cardiac Marker Market Other Major And Innovative Companies

31.1. Beckman Coulter Inc.

31.2. Bio-Rad Laboratories Inc.

31.3. Thermo Fisher Scientific Inc.

31.4. Guangzhou Wondifo Biotech Co. Ltd.

31.5. Creative Diagnostics

31.6. PerkinElmer Inc.

31.7. Tosoh Corporation

31.8. Quidel Corporation

31.9. Randox Laboratories Ltd.

31.10. Getinge Group

31.11. LSI Medience Corporation

31.12. Ortho Clinical Diagnostics

31.13. DiaSorin

31.14. 3M Company

31.15. Atom Medical Corporation

32. Global Cardiac Marker Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Marker Market

34. Recent Developments In The Cardiac Marker Market

35. Cardiac Marker Market High Potential Countries, Segments and Strategies

35.1 Cardiac Marker Market In 2029 - Countries Offering Most New Opportunities

35.2 Cardiac Marker Market In 2029 - Segments Offering Most New Opportunities

35.3 Cardiac Marker Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Cardiac Marker Market, Sub-Segmentation Of Troponin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Cardiac Marker Market, Sub-Segmentation Of Creatine Kinase-MB (CK-MB), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Cardiac Marker Market, Sub-Segmentation Of B-Type Natriuretic Peptide (BNP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Cardiac Marker Market, Sub-Segmentation Of Myoglobin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Cardiac Marker Market, Sub-Segmentation Of Other Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Cardiac Marker Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Cardiac Marker Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Abbott Laboratories Inc. Financial Performance
  • Table 81: Siemens AG Financial Performance
  • Table 82: Danaher Corporation Financial Performance
  • Table 83: BioMérieux SA Financial Performance
  • Table 84: F. Hoffmann-La Roche AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Cardiac Marker Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Cardiac Marker Market, Sub-Segmentation Of Troponin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Cardiac Marker Market, Sub-Segmentation Of Creatine Kinase-MB (CK-MB), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Cardiac Marker Market, Sub-Segmentation Of B-Type Natriuretic Peptide (BNP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Cardiac Marker Market, Sub-Segmentation Of Myoglobin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Cardiac Marker Market, Sub-Segmentation Of Other Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Cardiac Marker Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Cardiac Marker Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Cardiac Marker Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Cardiac Marker Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Cardiac Marker Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Abbott Laboratories Inc. Financial Performance
  • Figure 81: Siemens AG Financial Performance
  • Figure 82: Danaher Corporation Financial Performance
  • Figure 83: BioMérieux SA Financial Performance
  • Figure 84: F. Hoffmann-La Roche AG Financial Performance

Major Drivers Propelling the Growth oh theIntravenous Stopcock Market Forward: Rising Demand For Accurate Fluid Control Devices Fueling The Growth Of The Market Due To Enhanced Medication Precision And Patient Safety

Read More About Major Drivers Propelling the Growth oh theIntravenous Stopcock Market Forward: Rising Demand For Accurate Fluid Control Devices Fueling The Growth Of The Market Due To Enhanced Medication Precision And Patient Safety

Major Trends and Emerging Patterns in the Personal Emergency Response Systems (PERS) Market: Advanced Medical Alert Devices Enhancing Emergency Response And Healthcare Management

Read More About Major Trends and Emerging Patterns in the Personal Emergency Response Systems (PERS) Market: Advanced Medical Alert Devices Enhancing Emergency Response And Healthcare Management

Key Factors Fueling the Growth of the Physiotherapy Equipment Market in 2025: Rising Osteoporosis Cases Driving The Growth Of The Market Due To Increasing Aging Population And Sedentary Lifestyles

Read More About Key Factors Fueling the Growth of the Physiotherapy Equipment Market in 2025: Rising Osteoporosis Cases Driving The Growth Of The Market Due To Increasing Aging Population And Sedentary Lifestyles

Critical Market Drivers Shaping the Outlook for Positive Air Pressure Devices Market from 2025-2034: Rising Prevalence Of Respiratory Disorders Fueling The Growth Of The Market Due To Increasing Demand For Effective Breathing Solutions

Read More About Critical Market Drivers Shaping the Outlook for Positive Air Pressure Devices Market from 2025-2034: Rising Prevalence Of Respiratory Disorders Fueling The Growth Of The Market Due To Increasing Demand For Effective Breathing Solutions

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the lichen planus market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical syringe drive systems market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the medical syringe drive systems market backed by expert analysis and data-driven projections.

Joint Reconstruction Devices And Equipment Market 2021 - By Type (Knee Reconstruction Devices, Hip Reconstruction Devices, Extremity Reconstruction Devices), By Application (Arthrodesis, Arthroscopy, Joint Replacement Su...

View Report

Dialysis Devices And Equipment Market 2021 - By Product (Hemodialysis Devices, Peritoneal Dialysis Devices, Continuous Renal Replacement Therapy (CRRT) Systems, Consumables), By End-User (Hospitals And Clinics, Ambulator...

View Report

COVID-19 Rapid Test Kits Market 2022 – By Test Type (RT PCR Test, Rapid Antigen Test, Rapid Antibody Test, Others), By Test Components (PCR Machines, Equipment And Extraction Kits, Reagents), By Specimen Type (Nasopharyn...

View Report

Pulse Oximeters and Spirometers Market - By Product Type (Pulse Oximeters, Spirometers), Type Of Device (Handheld, Fingertip), By Application (Diagnostic, Treatment Monitoring), By Patient Type (Asthma, COPD), By End-Use...

View Report

Wearable Blood Pressure Monitors Market - By Product (Upper Arm Blood Pressure Monitor, Wrist Blood Pressure Monitor, Finger Blood Pressure Monitor), And By Region, Opportunities And Strategies - Global Forecast To 2030...

View Report

Sterilization Equipment And Disinfectants Market 2023 – By Product Type (Sterilization Equipment, Disinfectants), By Method (Physical Method, Chemical Method, Mechanical Method), By End Use (Hospitals And Clinics, Clinic...

View Report

Diagnostic Equipment Global Market Report 2022 – By Type (X-Ray Systems, Ultrasound Systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging Systems, Cardiovascular Monitoring And Diagnostic Devices, and Nu...

View Report

Methanol Market - By End Use (Formaldehyde, Mto/Mtp, Fuel Blending, Dimethyl Ether, Acetic Acid, Methyl Tert-Butyl Ether (Mtbe), Solvents, Methylamines, Mma, Chloro-Methanes), By Type Of Product( Plastics & Polymers, Chl...

View Report

Frequently Asked Questions

Cardiac markers are biomolecules that are released into the bloodstream when there is damage or stress to the heart muscle. It is used to diagnose and monitor a variety of cardiac diseases, including heart attacks, angina, and heart failure. For further insights on this market, request a sample here

The market major growth driver - Cardiac Marker Market Surge Is Addressing The Growing Prevalence Of Cardiovascular Diseases. For further insights on this market, request a sample here

The cardiac marker market size has grown strongly in recent years. It will grow from $11.26 billion in 2024 to $12.38 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increased incidence of cardiovascular diseases, aging population and cardiovascular risk, awareness programs and health screenings, integration of biomarkers in clinical practice, stringent regulatory standards and guidelines. The cardiac marker market size is expected to see rapid growth in the next few years. It will grow to $20.05 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to rising burden of lifestyle-related diseases, remote monitoring and telemedicine, personalized medicine and precision diagnostics, point-of-care testing (poct) adoption, collaborations and partnerships in healthcare. Major trends in the forecast period include biomarker discovery and validation, personalized medicine approaches, technological advancements in assay platforms, integration of high-sensitivity troponin tests, rise in cardiovascular disease prevalence. For further insights on this market, request a sample here

The cardiac markermarket covered in this report is segmented –
1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers
2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA
3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications
4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions Subsegments:
1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits
2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels
3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels
4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels
5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP) For further insights on this market, request a sample here

North America was the largest region in the cardiac marker market in 2024. The regions covered in the cardiac marker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the cardiac marker market include Abbott Laboratories Inc., Siemens AG, Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Guangzhou Wondifo Biotech Co. Ltd., Creative Diagnostics, PerkinElmer Inc., Tosoh Corporation, Quidel Corporation, Randox Laboratories Ltd., Getinge Group, LSI Medience Corporation, Ortho Clinical Diagnostics, DiaSorin, 3M Company, Atom Medical Corporation, Bionet America Inc., Bistos Inc., CareFusion Corporation, Clinical Innovations LLC, Abcam plc, General Electric Company . For further insights on this market, request a sample here.

Major trends in this market include Mirxes' Microrna-Based Diagnostic Test Revolutionizes Early Detection In The Cardiac Marker Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Cardiac Marker Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top